Literature DB >> 32669927

Preparing for the renaissance: treating breast cancer during the COVID-19 pandemic and planning for a safe re-emergence to routine surgical care within a universal health care system.

D Berger-Richardson1, G Ko1, N J Look Hong1,2,3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32669927      PMCID： PMC7339859          DOI： 10.3747/co.27.6699

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  20 in total

1.  Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma In Situ.

Authors:  Meghna S Trivedi; Austin M Coe; Alejandro Vanegas; Rita Kukafka; Katherine D Crew
Journal:  Cancer Prev Res (Phila)       Date:  2017-06-13

2.  Tamoxifen increases the risk of microvascular flap complications in patients undergoing microvascular breast reconstruction.

Authors:  Brian P Kelley; Vicente Valero; Min Yi; Steven J Kronowitz
Journal:  Plast Reconstr Surg       Date:  2012-02       Impact factor: 4.730

Review 3.  Stopping tamoxifen peri-operatively for VTE risk reduction: a proposed management algorithm.

Authors:  Tasadooq Hussain; Peter J Kneeshaw
Journal:  Int J Surg       Date:  2012-05-16       Impact factor: 6.071

4.  Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.

Authors:  Lotte E Elshof; Konstantinos Tryfonidis; Leen Slaets; A Elise van Leeuwen-Stok; Victoria P Skinner; Nicolas Dif; Ruud M Pijnappel; Nina Bijker; Emiel J Th Rutgers; Jelle Wesseling
Journal:  Eur J Cancer       Date:  2015-05-26       Impact factor: 9.162

5.  Neoadjuvant Radiotherapy: Changing the Treatment Sequence to Allow Immediate Free Autologous Breast Reconstruction.

Authors:  Kimberley Hughes; Derek Neoh
Journal:  J Reconstr Microsurg       Date:  2018-06-16       Impact factor: 2.873

Review 6.  Squamous-cell carcinoma of the anus: progress in radiotherapy treatment.

Authors:  Rob Glynne-Jones; David Tan; Robert Hughes; Peter Hoskin
Journal:  Nat Rev Clin Oncol       Date:  2016-01-27       Impact factor: 66.675

7.  Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.

Authors:  Gunter von Minckwitz; Chiun-Sheng Huang; Max S Mano; Sibylle Loibl; Eleftherios P Mamounas; Michael Untch; Norman Wolmark; Priya Rastogi; Andreas Schneeweiss; Andres Redondo; Hans H Fischer; William Jacot; Alison K Conlin; Claudia Arce-Salinas; Irene L Wapnir; Christian Jackisch; Michael P DiGiovanna; Peter A Fasching; John P Crown; Pia Wülfing; Zhimin Shao; Elena Rota Caremoli; Haiyan Wu; Lisa H Lam; David Tesarowski; Melanie Smitt; Hannah Douthwaite; Stina M Singel; Charles E Geyer
Journal:  N Engl J Med       Date:  2018-12-05       Impact factor: 176.079

8.  Pleomorphic lobular carcinoma in situ: Current evidence and a systemic review.

Authors:  Umar Wazir; Ali Wazir; Clive Wells; Kefah Mokbel
Journal:  Oncol Lett       Date:  2016-11-01       Impact factor: 2.967

9.  The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS).

Authors:  E Shelley Hwang; Terry Hyslop; Thomas Lynch; Elizabeth Frank; Donna Pinto; Desiree Basila; Deborah Collyar; Antonia Bennett; Celia Kaplan; Shoshana Rosenberg; Alastair Thompson; Anna Weiss; Ann Partridge
Journal:  BMJ Open       Date:  2019-03-12       Impact factor: 2.692

10.  Preoperative Delays in the Treatment of DCIS and the Associated Incidence of Invasive Breast Cancer.

Authors:  William H Ward; Lyudmila DeMora; Elizabeth Handorf; Elin R Sigurdson; Eric A Ross; John M Daly; Allison A Aggon; Richard J Bleicher
Journal:  Ann Surg Oncol       Date:  2019-09-27       Impact factor: 5.344
View more
  4 in total

Review 1.  Triple-Negative Breast Cancer and the COVID-19 Pandemic: Clinical Management Perspectives and Potential Consequences of Infection.

Authors:  Justin M Brown; Marie-Claire D Wasson; Paola Marcato
Journal:  Cancers (Basel)       Date:  2021-01-15       Impact factor: 6.639

Review 2.  When to operate after SARS-CoV-2 infection? A review on the recent consensus recommendation of the DGC/BDC and the DGAI/BDA.

Authors:  J Noll; M Reichert; M Dietrich; J G Riedel; M Hecker; W Padberg; M A Weigand; A Hecker
Journal:  Langenbecks Arch Surg       Date:  2022-03-21       Impact factor: 2.895

Review 3.  Analysis of Facilitators and Barriers to the Delivery of Routine Care during the COVID-19 Global Pandemic: A Systematic Review.

Authors:  Cristian Lieneck; Brooke Herzog; Raven Krips
Journal:  Healthcare (Basel)       Date:  2021-05-01

Review 4.  Neoadjuvant Chemotherapy in Breast Cancer: Review of the Evidence and Conditions That Facilitated Its Use during the Global Pandemic.

Authors:  Tabitha Tse; Sandeep Sehdev; Jean Seely; Denis H Gravel; Mark Clemons; Erin Cordeiro; Angel Arnaout
Journal:  Curr Oncol       Date:  2021-03-24       Impact factor: 3.677
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.